SFTPB and cancer: In the present study, we evaluated the possibility that low expression of pro-SFTPB in cancer tissue compared to adjacent tissue is a predictor of early-stage NSCLC recurrence and elucidated the mechanism by which downregulation of pro-SFTPB expression promotes early-stage NSCLC recurrence.